Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP505495.RAg59DTE6DcYZ9Otjd_u_wE7Rc5UvkhgvjAGDQ12Ll9ds130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP505495.RAg59DTE6DcYZ9Otjd_u_wE7Rc5UvkhgvjAGDQ12Ll9ds130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP505495.RAg59DTE6DcYZ9Otjd_u_wE7Rc5UvkhgvjAGDQ12Ll9ds130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP505495.RAg59DTE6DcYZ9Otjd_u_wE7Rc5UvkhgvjAGDQ12Ll9ds130_provenance.
- NP505495.RAg59DTE6DcYZ9Otjd_u_wE7Rc5UvkhgvjAGDQ12Ll9ds130_assertion description "[Interleukin-6, IL-11 and other members of the gp130 cytokine family have been identified in preclinical mouse models as promising therapeutic targets for gastrointestinal, hepatic and breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505495.RAg59DTE6DcYZ9Otjd_u_wE7Rc5UvkhgvjAGDQ12Ll9ds130_provenance.
- NP505495.RAg59DTE6DcYZ9Otjd_u_wE7Rc5UvkhgvjAGDQ12Ll9ds130_assertion evidence source_evidence_literature NP505495.RAg59DTE6DcYZ9Otjd_u_wE7Rc5UvkhgvjAGDQ12Ll9ds130_provenance.
- NP505495.RAg59DTE6DcYZ9Otjd_u_wE7Rc5UvkhgvjAGDQ12Ll9ds130_assertion SIO_000772 22211709 NP505495.RAg59DTE6DcYZ9Otjd_u_wE7Rc5UvkhgvjAGDQ12Ll9ds130_provenance.
- NP505495.RAg59DTE6DcYZ9Otjd_u_wE7Rc5UvkhgvjAGDQ12Ll9ds130_assertion wasDerivedFrom befree-20150227 NP505495.RAg59DTE6DcYZ9Otjd_u_wE7Rc5UvkhgvjAGDQ12Ll9ds130_provenance.
- NP505495.RAg59DTE6DcYZ9Otjd_u_wE7Rc5UvkhgvjAGDQ12Ll9ds130_assertion wasGeneratedBy ECO_0000203 NP505495.RAg59DTE6DcYZ9Otjd_u_wE7Rc5UvkhgvjAGDQ12Ll9ds130_provenance.
- befree-20150227 importedOn "2015-02-27" NP505495.RAg59DTE6DcYZ9Otjd_u_wE7Rc5UvkhgvjAGDQ12Ll9ds130_provenance.